Yahoo Web Search

Search results

    • FDA clears GSK's RSV vaccine for adults ages 50-59

      FDA clears GSK's RSV vaccine for adults ages 50-59

      United Press International via Yahoo News· 54 minutes ago

      The U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...